Share-based Payment Arrangements (Tables)

9 Months Ended

Sep. 26, 2020

Amounts Recognized in Financial Statements with Respect to Plans

Amounts recognized in the financial statements with respect to these Plans are as follows (in thousands):

	Thirty Nine Weeks Ended						Thirteen Weeks Ended
	September 26, 2020			September 28, 2019			September 26, 2020			September 28, 2019
Total cost of the Plans during the period	$	2,691		$	4,470		$	1,490		$	1,102
Amount of related income tax benefit recognized during the period		(1,618	)		(4,125	)		(483	)		(391	)
Net cost of the Plans during the period		$ 1,073		$	345		$	1,007		$	711

Summary of Information Regarding Stock Options

The following table summarizes information regarding the Company’s outstanding stock options under the Plans:

	Number of Options			Weighted Average Exercise Price per Share		Weighted Average Remaining Contractual Term (years)		Aggregate Intrinsic Value (000s)
Options outstanding at December 28, 2019		44,467		$	51.24
Exercised		(23,717	)	$	49.31
Options outstanding at September 26, 2020		20,750		$	53.44		1.9	$	1,499
Options exercisable at September 26, 2020		20,750		$	53.44		1.9	$	1,499

Restricted Stock Units (RSUs)

Schedule of Information on Restricted Stock Units

The following table summarizes information regarding the Company’s outstanding restricted stock unit (“RSU”) awards with either a performance condition or a market condition under the Plans:

	Number of RSUs			Weighted Average Grant Date Fair Value
Outstanding at December 28, 2019		198,875		$	84.37
Granted		59,719		$	102.62
Shares earned in excess of target (1)		11,648		$	77.00
Vested shares, including shares earned in excess of target		(76,290	)	$	73.44
Forfeited		(10,987	)	$	100.55
Outstanding at September 26, 2020		182,965		$	93.44

(1) Represents additional shares earned under the February 2, 2017 RSU awards as 2019 financial results exceeded target performance level.

Non Vested Restricted Stock and Deferred Stock Units

Schedule of Information on Non-Vested Restricted Stock and Deferred Stock Units

The following table summarizes information regarding the Company’s outstanding shares of non-vested restricted stock and Deferred Stock Units (defined below) under the Plans:

	Number of Shares and Deferred Stock Units			Weighted Average Grant Date Fair Value
Non-vested at December 28, 2019		64,808		$	98.24
Granted		26,604		$	111.88
Vested		(28,621	)	$	98.83
Forfeited		(2,351	)	$	106.34
Non-vested at September 26, 2020		60,440		$	103.65